MUAMU
PVLA

Mitsubishi UFJ Asset Management (UK)’s Palvella Therapeutics PVLA Stock Holding History

Mitsubishi UFJ Asset Management (UK)’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$841K Buy
+5,500
New +$668K 0.39% 71

Other funds holding PVLA

CAM
Clio Asset Management Charlottesville, Virginia $126M AUM 16.01% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
AL
Aspiriant LLC Los Angeles, California $4.05B AUM 19.01% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
C
Certuity North Palm Beach, Florida $2.03B AUM 88.59% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

Mitsubishi UFJ Asset Management (UK)'s PVLA Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management (UK) opened a new position in Palvella Therapeutics (PVLA) in Q2 2026: 5,500 shares worth $841K. The stake represents 0.39% of the portfolio and ranks #71 among its holdings.

23 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

  • Mitsubishi UFJ Asset Management (UK) held 5,500 shares of Palvella Therapeutics worth $841K as of Q2 2026.
  • Palvella Therapeutics was a new Mitsubishi UFJ Asset Management (UK) position in Q2 2026.
  • Palvella Therapeutics made up 0.39% of Mitsubishi UFJ Asset Management (UK)'s portfolio in Q2 2026, its #71 holding.
  • 23 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on Mitsubishi UFJ Asset Management (UK)'s 13F filing for Q2 2026, filed 28 Jul 2026.